The Food and Drug Administration (FDA) announced plans to significantly curtail people’s access to Covid-19 vaccines.

The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...

Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...

The U.S. Food and Drug Administration’s decision to limit COVID vaccines to people 65 and older and others with underlying ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

As the Trump administration’s FDA moves to limit approval for COVID-19 booster shots, millions of Americans under 65 may find ...